Trgovina VYNE Therapeutics Inc. - VYNE CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Pogoji trgovanja
| Razmik | 0.20 | ||||||||
|
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.025457% | ||||||||
|
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.003235% | ||||||||
| Čas nočne pristojbine | 21:00 (UTC) | ||||||||
| Min. tržena količina | 1 | ||||||||
| Valuta | USD | ||||||||
| Kritje | 20% | ||||||||
| Borza | United States of America | ||||||||
| Provizija na trgovanje | 0% |
*Information provided by Capital.com
Vyne Therapeutics Inc ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Ključni statistični podatki
| Predhodno. Zapri* | 6.07 |
| Odpri* | 5.85 |
| Enoletna sprememba* | 1439.47% |
| Dnevni razpon* | 5.76 - 6.35 |
| Razpon 52 wk | 1.99-9.90 |
| Povprečni obseg (10 dni) | 36.22K |
| Povprečni obseg (3 meseci) | 15.26M |
| Tržna kapitalizacija | 19.82M |
| Razmerje P/E | -100.00K |
| Število delnic v obtoku | 3.27M |
| Prihodki | 398.00K |
| EPS | -9.57 |
| Dividenda (donosnost v %) | N/A |
| Beta | 1.60 |
| Datum naslednjega zaslužka | Aug 10, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
|---|---|---|---|---|---|---|
| Jun 2, 2023 | 5.93 | -0.05 | -0.84% | 5.98 | 6.36 | 5.76 |
| Jun 1, 2023 | 6.07 | -0.16 | -2.57% | 6.23 | 6.23 | 6.04 |
| May 31, 2023 | 6.26 | -0.11 | -1.73% | 6.37 | 6.38 | 6.22 |
| May 30, 2023 | 6.38 | -0.18 | -2.74% | 6.56 | 6.58 | 6.24 |
| May 26, 2023 | 6.48 | -0.38 | -5.54% | 6.86 | 6.97 | 6.46 |
| May 25, 2023 | 6.96 | 0.10 | 1.46% | 6.86 | 7.31 | 6.59 |
| May 24, 2023 | 6.85 | -0.31 | -4.33% | 7.16 | 7.16 | 6.58 |
| May 23, 2023 | 7.25 | 0.39 | 5.69% | 6.86 | 7.66 | 6.86 |
| May 22, 2023 | 6.93 | 0.14 | 2.06% | 6.79 | 7.01 | 6.79 |
| May 19, 2023 | 6.76 | 0.14 | 2.11% | 6.62 | 6.87 | 6.32 |
| May 18, 2023 | 6.73 | -0.23 | -3.30% | 6.96 | 6.99 | 6.22 |
| May 17, 2023 | 7.05 | 0.19 | 2.77% | 6.86 | 7.13 | 6.76 |
| May 16, 2023 | 6.87 | -0.35 | -4.85% | 7.22 | 7.46 | 6.61 |
| May 15, 2023 | 7.54 | 0.35 | 4.87% | 7.19 | 7.63 | 7.18 |
| May 12, 2023 | 7.14 | 0.61 | 9.34% | 6.53 | 7.38 | 6.53 |
| May 11, 2023 | 6.08 | 0.30 | 5.19% | 5.78 | 6.62 | 5.78 |
| May 10, 2023 | 5.93 | -1.74 | -22.69% | 7.67 | 7.67 | 5.54 |
| May 9, 2023 | 7.65 | -1.01 | -11.66% | 8.66 | 8.66 | 7.34 |
| May 8, 2023 | 8.54 | 0.66 | 8.38% | 7.88 | 8.56 | 7.84 |
| May 5, 2023 | 7.93 | 1.14 | 16.79% | 6.79 | 8.11 | 6.79 |
VYNE Therapeutics Inc. Events
| Čas (UTC) (UTC) | Država | Dogodek |
|---|---|---|
| Monday, June 5, 2023 | ||
| Čas (UTC) (UTC) 10:59 | Država US
| Dogodek Vyne Therapeutics Inc at Biotechnology Industry Organization (BIO) International Convention Vyne Therapeutics Inc at Biotechnology Industry Organization (BIO) International ConventionForecast -Previous - |
| Thursday, August 10, 2023 | ||
| Čas (UTC) (UTC) 12:30 | Država US
| Dogodek Q2 2023 Vyne Therapeutics Inc Earnings Release Q2 2023 Vyne Therapeutics Inc Earnings ReleaseForecast -Previous - |
| Čas (UTC) (UTC) 14:00 | Država US
| Dogodek Vyne Therapeutics Inc Annual Shareholders Meeting Vyne Therapeutics Inc Annual Shareholders MeetingForecast -Previous - |
| Wednesday, November 8, 2023 | ||
| Čas (UTC) (UTC) 10:59 | Država US
| Dogodek Q3 2023 Vyne Therapeutics Inc Earnings Release Q3 2023 Vyne Therapeutics Inc Earnings ReleaseForecast -Previous - |
- Letni
- Četrtletno
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Skupni prihodki | 0.477 | 0.931 | 20.993 | 0 | 10.64 |
| Prihodki | 0.477 | 0.931 | 20.993 | 0 | 10.64 |
| Celotni odhodki iz poslovanja | 34.772 | 39.842 | 273.539 | 76.242 | 65.175 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 16.387 | 20.299 | 89.543 | 22.481 | 12.186 |
| Raziskave in razvoj | 18.385 | 19.543 | 43.533 | 53.761 | 52.989 |
| Prihodki iz poslovanja | -34.295 | -38.911 | -252.546 | -76.242 | -54.535 |
| Prihodki (odhodki) od obresti, neto Neoperativni | 0 | -5.61 | -4.39 | 2.539 | 3.09 |
| Čisti dobiček pred obdavčitvijo | -33.932 | -44.656 | -255.826 | -73.703 | -51.445 |
| Čisti dobiček po davkih | -33.945 | -44.208 | -255.568 | -73.703 | -51.445 |
| Čisti dobiček pred dodatnimi postavkami | -33.945 | -44.208 | -255.568 | -73.703 | -51.445 |
| Čisti dobiček | -23.21 | -73.329 | -255.568 | -73.703 | -51.445 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -33.945 | -44.208 | -255.568 | -73.703 | -51.445 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -23.21 | -73.329 | -255.568 | -73.703 | -51.445 |
| Popravljen čisti dobiček | -23.21 | -73.329 | -255.568 | -73.703 | -51.445 |
| Popravljene ponderirane povprečne delnice | 3.186 | 2.859 | 1.80114 | 0.33084 | 0.30098 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -10.6544 | -15.4628 | -141.892 | -222.774 | -170.926 |
| Dividends per Share - Common Stock Primary Issue | |||||
| Popravljen normalizirani dobiček na enoto čistega dobička | -10.6544 | -15.4628 | -141.892 | -222.774 | -170.926 |
| Skupaj izredne postavke | 10.735 | -29.121 | |||
| Celotni stroški prihodkov | 1.392 | ||||
| Bruto dobiček | 19.601 | ||||
| Other Operating Expenses, Total | 139.071 | ||||
| Drugo, neto | 0.363 | -0.135 | 1.11 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Skupni prihodki | 0.099 | 0.006 | 0.167 | 0.126 | 0.178 |
| Prihodki | 0.099 | 0.006 | 0.167 | 0.126 | 0.178 |
| Celotni odhodki iz poslovanja | 5.974 | 7.99 | 9.5 | 8.413 | 8.869 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 3.24 | 3.711 | 3.954 | 4.305 | 4.417 |
| Raziskave in razvoj | 2.734 | 4.279 | 5.546 | 4.108 | 4.452 |
| Prihodki iz poslovanja | -5.875 | -7.984 | -9.333 | -8.287 | -8.691 |
| Prihodki (odhodki) od obresti, neto Neoperativni | 0 | 0 | 0 | 0 | |
| Drugo, neto | 0.263 | 0.236 | 0.078 | 0.052 | -0.003 |
| Čisti dobiček pred obdavčitvijo | -5.612 | -7.748 | -9.255 | -8.235 | -8.694 |
| Čisti dobiček po davkih | -5.612 | -7.761 | -9.255 | -8.235 | -8.694 |
| Čisti dobiček pred dodatnimi postavkami | -5.612 | -7.761 | -9.255 | -8.235 | -8.694 |
| Skupaj izredne postavke | -0.01 | -2.184 | -0.204 | -0.241 | 13.364 |
| Čisti dobiček | -5.622 | -9.945 | -9.459 | -8.476 | 4.67 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -5.612 | -7.761 | -9.255 | -8.235 | -8.694 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -5.622 | -9.945 | -9.459 | -8.476 | 4.67 |
| Popravljen čisti dobiček | -5.622 | -9.945 | -9.459 | -8.476 | 4.67 |
| Popravljene ponderirane povprečne delnice | 3.255 | 3.2245 | 3.21833 | 3.21859 | 3.07725 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -1.72412 | -2.40688 | -2.87571 | -2.55857 | -2.82525 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Popravljen normalizirani dobiček na enoto čistega dobička | -1.72412 | -2.40688 | -2.87571 | -2.55857 | -2.82525 |
| Celotni stroški prihodkov | |||||
| Bruto dobiček | |||||
| Other Operating Expenses, Total |
- Letni
- Četrtletno
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 38.275 | 63.186 | 87.259 | 76.414 | 139.5 |
| Denarna sredstva in kratkoročne naložbe | 30.908 | 42.25 | 57.563 | 55.861 | 136.25 |
| Denarna sredstva in ustrezniki | 30.908 | 42.25 | 57.563 | 43.759 | 49.51 |
| Kratkoročne naložbe | 12.102 | 86.74 | |||
| Prepaid Expenses | 2.127 | 5.119 | 4.591 | 1.557 | 3.25 |
| Total Assets | 40.758 | 67.046 | 93.742 | 81.159 | 139.928 |
| Property/Plant/Equipment, Total - Net | 0 | 0.354 | 2.138 | 4.579 | 0.146 |
| Long Term Investments | 0 | ||||
| Other Long Term Assets, Total | 2.483 | 3.506 | 4.345 | 0.166 | 0.282 |
| Total Current Liabilities | 9.345 | 18.41 | 21.765 | 29.326 | 9.544 |
| Accounts Payable | 2.386 | 6.51 | 4.78 | 19.352 | 3.29 |
| Accrued Expenses | 4.381 | 8.942 | 12.209 | 4.473 | 5.998 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 2.578 | 2.958 | 4.776 | 5.501 | 0.256 |
| Total Liabilities | 9.345 | 18.41 | 56.249 | 63.584 | 9.551 |
| Total Long Term Debt | 0 | 0 | 33.174 | 32.725 | 0 |
| Other Liabilities, Total | 0 | 1.31 | 1.533 | 0.007 | |
| Total Equity | 31.413 | 48.636 | 37.493 | 17.575 | 130.377 |
| Preferred Stock - Non Redeemable, Net | 0 | ||||
| Common Stock | 0 | 0.005 | 0.004 | 0.003 | 0.003 |
| Additional Paid-In Capital | 693.937 | 688.156 | 603.685 | 328.154 | 241.106 |
| Retained Earnings (Accumulated Deficit) | -662.735 | -639.525 | -566.196 | -310.587 | -110.636 |
| Unrealized Gain (Loss) | 0 | 0 | 0.005 | -0.096 | |
| Total Liabilities & Shareholders’ Equity | 40.758 | 67.046 | 93.742 | 81.159 | 139.928 |
| Total Common Shares Outstanding | 3.2297 | 2.97678 | 2.40048 | 0.50671 | 0.32271 |
| Celotne terjatve, neto | 5.173 | 7.583 | 15.819 | 0.135 | 0 |
| Accounts Receivable - Trade, Net | 0.173 | 7.583 | 15.819 | 0.135 | 0 |
| Redeemable Preferred Stock | 0.211 | ||||
| Total Inventory | 7.291 | 7.404 | 1.356 | ||
| Other Current Assets, Total | 0.067 | 0.943 | 1.882 | 17.505 | |
| Goodwill, Net | 0 | ||||
| Long Term Debt | 0 | 33.174 | 32.725 | ||
| Property/Plant/Equipment, Total - Gross | 0.905 | 2.581 | |||
| Accumulated Depreciation, Total | -0.551 | -0.443 | |||
| Total Preferred Shares Outstanding | 0.003 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 33.022 | 38.275 | 44.046 | 51.92 | 60.654 |
| Denarna sredstva in kratkoročne naložbe | 30.213 | 30.908 | 35.51 | 42.814 | 50.495 |
| Denarna sredstva in ustrezniki | 30.213 | 30.908 | 35.51 | 42.814 | 50.495 |
| Celotne terjatve, neto | 0.105 | 5.173 | 5.471 | 5.304 | 5.535 |
| Accounts Receivable - Trade, Net | 0.105 | 0.173 | 0.471 | 0.304 | 0.535 |
| Total Inventory | |||||
| Prepaid Expenses | 2.637 | 2.127 | 2.998 | 3.772 | 3.895 |
| Other Current Assets, Total | 0.067 | 0.067 | 0.067 | 0.03 | 0.729 |
| Total Assets | 35.263 | 40.758 | 46.908 | 55.192 | 64.319 |
| Property/Plant/Equipment, Total - Net | 0 | 0.127 | 0.298 | 0.31 | |
| Other Long Term Assets, Total | 2.241 | 2.483 | 2.735 | 2.974 | 3.355 |
| Total Current Liabilities | 7.519 | 9.345 | 6.839 | 6.835 | 8.588 |
| Accounts Payable | 2.214 | 2.386 | 2.523 | 1.431 | 3.612 |
| Accrued Expenses | 4.189 | 4.381 | 2.164 | 3.545 | 3.429 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 1.116 | 2.578 | 2.152 | 1.859 | 1.547 |
| Total Liabilities | 8.832 | 9.345 | 6.839 | 6.835 | 8.588 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Long Term Debt | |||||
| Other Liabilities, Total | 1.313 | ||||
| Total Equity | 26.431 | 31.413 | 40.069 | 48.357 | 55.731 |
| Common Stock | 0 | 0 | 0.006 | 0.006 | 0.006 |
| Additional Paid-In Capital | 694.937 | 693.937 | 692.853 | 691.682 | 690.58 |
| Retained Earnings (Accumulated Deficit) | -668.506 | -662.735 | -652.79 | -643.331 | -634.855 |
| Total Liabilities & Shareholders’ Equity | 35.263 | 40.758 | 46.908 | 55.192 | 64.319 |
| Total Common Shares Outstanding | 3.27128 | 3.2297 | 3.22447 | 3.22279 | 3.2174 |
| Current Port. of LT Debt/Capital Leases | |||||
| Unrealized Gain (Loss) | |||||
| Redeemable Preferred Stock | 0 | 0.211 | |||
| Total Preferred Shares Outstanding | 0 |
- Letni
- Četrtletno
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Čisti prihodki/začetna postavka | -23.21 | -73.329 | -255.568 | -73.703 | -51.445 |
| Denarna sredstva iz poslovanja | -29.2 | -56.367 | -137.082 | -65.101 | -52.733 |
| Denarna sredstva iz poslovanja | 0.072 | 0.109 | 0.341 | 0.056 | 0.022 |
| Nedenarne postavke | -8.339 | 12.077 | 158.476 | 6.654 | 2.864 |
| Spremembe v obratnem kapitalu | 2.277 | 4.776 | -40.331 | 1.892 | -4.174 |
| Denarna sredstva pri naložbenju | 15.667 | 1.027 | 89.107 | 41.374 | -33.876 |
| Kapitalski izdatki | 0 | -0.113 | -0.011 | -0.14 | |
| Celotne druge postavke denarnih tokov pri naložbenju | 15.667 | 1.027 | 89.22 | 41.385 | -33.736 |
| Denarna sredstva pri financiranju | 1.653 | 39.777 | 61.808 | 4.994 | 125.913 |
| Postavke denarnega toka pri financiranju | 0 | -0.294 | -0.141 | 0 | 0 |
| Izdaja (odplačilo) delnic, neto | 1.653 | 76.503 | 61.949 | 4.994 | 125.913 |
| Neto sprememba denarnih sredstev | -11.88 | -15.563 | 13.834 | -18.733 | 39.304 |
| Denarna sredstva Plačane obresti | 0 | 2.385 | 3.941 | ||
| Izdaja (odplačilo) dolga, neto | 0 | -36.432 | 0 | ||
| Učinki deviznih tečajev | 0 | 0.001 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -5.622 | -23.21 | -13.265 | -3.806 | 4.67 |
| Cash From Operating Activities | -5.478 | -29.2 | -25.325 | -18.2 | -9.039 |
| Cash From Operating Activities | 0 | 0.072 | 0.227 | 0.056 | 0.044 |
| Non-Cash Items | 0.856 | -8.339 | -9.686 | -10.899 | -12.102 |
| Cash Interest Paid | 0 | 0 | 0 | ||
| Changes in Working Capital | -0.712 | 2.277 | -2.601 | -3.551 | -1.651 |
| Cash From Investing Activities | 5 | 15.667 | 16.602 | 16.688 | 15.752 |
| Capital Expenditures | |||||
| Other Investing Cash Flow Items, Total | 5 | 15.667 | 16.602 | 16.688 | 15.752 |
| Cash From Financing Activities | -0.217 | 1.653 | 1.445 | 1.471 | 1.532 |
| Issuance (Retirement) of Stock, Net | -0.217 | 1.653 | 1.445 | 1.471 | 1.532 |
| Foreign Exchange Effects | |||||
| Net Change in Cash | -0.695 | -11.88 | -7.278 | -0.041 | 8.245 |
| Issuance (Retirement) of Debt, Net | 0 | 0 | |||
| Financing Cash Flow Items | 0 |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group535K+
Borzni posredniki
87K+
Aktivne stranke mesečno
$113M+
Mesečni obseg naložb
$64M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
Trgovalna provizija
0
- 1:1
Vzvod
1:1
- 20
- 100
- 500
- 1000
- 10000
Naložbe
Velikost posla (finančni vzvod x naložba):
Odpiranje
Zapiranje
Kratka Dolga
VYNE Therapeutics Inc. Company profile
O družbi VYNE Therapeutics Inc.
VYNE Therapeutics Inc. je biofarmacevtsko podjetje. Podjetje se osredotoča na razvoj diferenciranih terapij za zdravljenje imunovnetnih stanj. Glavni kandidat za izdelek družbe, FMX114, ki je v fazi IIa, se ocenjuje za morebitno zdravljenje blagega do zmernega atopijskega dermatitisa (AD). Družba se ukvarja tudi s predkliničnimi fazami razvoja izdelkov, ki vsebujejo spojine zaviralcev bromodomena in ekstraterminalne domene (BET). Njen prvi kandidat za inhibitor BET v razvoju je VYN201, lokalno uporabljen zaviralec pan-BET, ki ga družba raziskuje pri različnih imunovnetnih boleznih, vključno z boleznimi kože. VYN202 je pan-BD BET inhibitor, ki ga razvija za zdravljenje bolezni, ki vključujejo številna in različna vnetja. Poleg tega družba še naprej raziskuje oportunistične transakcije, ki krepijo njen portfelj priprav, podpirajo njeno poslovanje in financirajo njeno prihodnjo rast.
| Industry: | Pharmaceuticals (NEC) |
685 Route 202/206, Suite 301A
BRIDGEWATER
NEW JERSEY 08807
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 535.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com